Wwox suppresses prostate cancer cell growth through modulation of ErbB2-mediated androgen receptor signaling

Haiyan R Qin1, Dimitrios Iliopoulos, Tatsuya Nakamura

  • 1Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.

Insights

The WWOX tumor suppressor gene, often lost in prostate cancer, inhibits cancer growth by blocking ERBB2 activation. WWOX

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The WWOX tumor suppressor gene's expression is frequently lost or reduced in various cancers, notably prostate cancer.
  • Previous research demonstrated that WWOX overexpression induces apoptosis and suppresses prostate cancer progression both in vitro and in vivo.

Purpose of the Study:

  • To investigate the specific molecular pathways through which WWOX exerts its tumor-suppressive effects on prostate cancer cell growth.
  • To elucidate the interaction between WWOX, Ap2gamma, and ERBB2 in the context of prostate cancer.

Main Methods:

  • Investigated the interaction between WWOX and Ap2gamma.
  • Assessed the effect of WWOX on the nuclear localization of Ap2gamma and its binding to the ERBB2 promoter.
  • Measured ERBB2 and prostate-specific antigen (PSA) expression levels.
  • Correlated WWOX and ErbB2 protein expression in prostate cancer tissues.

Main Results:

  • WWOX interacts with Ap2gamma, preventing its nuclear entry and subsequent activation of the ERBB2 promoter.
  • Ectopic WWOX expression reduced ErbB2 protein levels in vitro, and WWOX protein levels inversely correlated with ErbB2 protein levels in prostate cancer tissues.
  • WWOX suppressed Ap2gamma/ErbB2-mediated prostate cancer cell growth and PSA secretion, an effect dependent on functional androgen receptor signaling.

Conclusions:

  • WWOX acts as a critical regulator of prostate cancer cell proliferation by inhibiting the Ap2gamma/ERBB2 pathway, particularly under limiting androgen conditions.
  • The tumor-suppressive function of WWOX in prostate cancer is mediated through the down-modulation of ErbB2 and requires an intact androgen receptor pathway.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...